Also trades as: INXB (NASDAQ) · $vol 8M
INBX NASDAQ
Inhibrx Biosciences Inc.
1W: -1.9%
1M: -13.5%
3M: -36.1%
YTD: +9.9%
1Y: +257.4%
$79.68
-2.77 (-3.36%)
Weekly Expected Move ±8.1%
$68
$75
$82
$88
$95
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.2B
52W Range20.55-155.29
Volume185,773
Avg Volume401,630
Beta3.43
Dividend$0.85
Analyst Ratings
Company Info
CEOMark Lappe
Employees109
SectorHealthcare
IndustryBiotechnology
IPO Date2024-05-29
Websiteinhibrx.com
11025 North Torrey Pines Road
La Jolla, CA 92037
US
La Jolla, CA 92037
US
858-795-4220
About Inhibrx Biosciences Inc.
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.
Latest News
Price-Driven Insight from (INBX) for Rule-Based Strategy - Stock Traders Daily
What is Inhibrx Biosciences, Inc. (INBX) stock_business overview_development history - Bitget
INBX Stock Hit Record Highs: Retail Turns ‘Extremely Bullish’ On This Cancer Play - Stocktwits
Does Inhibrx Biosciences' (INBX) Shift Into Russell Growth Indexes Reframe Its Core Investment Story? - simplywall.st
Are You Looking for a Top Momentum Pick? Why Inhibrx Biosciences, Inc. (INBX) is a Great Choice
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Vuori Kristiina MD | A-Award | 15,000 | $95.22 | 2026-06-03 |
| Kayyem Jon Faiz | A-Award | 15,000 | $95.22 | 2026-06-03 |
| FORSYTH DOUGLAS | A-Award | 15,000 | $95.22 | 2026-06-03 |
| MANHARD KIMBERLY | A-Award | 15,000 | $95.22 | 2026-06-03 |
| Matly David | A-Award | 50,000 | $129.06 | 2026-04-24 |